LHV finantsportaal

Foorum Investeerimine

Börsipäev 26.detsember

Kommentaari jätmiseks loo konto või logi sisse

  • Häid jätkuvaid jõulupühi kõigile LHV foorumlastele!

    Enamus aktsiaturge on täna endiselt pühade tõttu suletud, aga USA turud on avatud ja kauplevad tavapärasel ajal 17.00-23.00.
    Pühade ajal on turuosalised natuke elu üle järele mõelnud ja otsustanud aasta lõpus kasumit võtta. Nasdaqi futuurid on kauplemas 0,66% miinuspoolel ja ES ning Dow Jones 0,2% madalamal.
  • Gapping up
    M&A:
    SCMP (+5%) Acquired by Mallinckrodt (MNK)
    News:
    IGC (+180%) Developing leverage existing assets to develop methods to utilize blockchain
    DMPI (+44%) FDA has granted Fast Track designation for the company's lead product candidate, VAL-083, in recurrent glioblastoma
    APTO (+37%) FDA grants orphan drug designation for CG'806 in Acute Myeloid Leukemia
    ONVO (+10%) FDA granted orphan drug designation for the Company's treatment of alpha-1 antitrypsin deficiency with its 3D bioprinted liver therapeutic tissue
    KED (+4%) Tax Cuts have positive impact on NAV
    Crypto stocks:
    IGC +172.36% LFIN +15.78% NETE +14.35% FTFT +12.64% RIOT +10.11% ONVO +7.59% OTIV +7.48% NXTD +7.48% TEUM +7.09% MARA +6.31% SIEB +5.83% DPW +4.87% JTPY +5.08% GLNNF +4.03% SRAX +3.14% OSTK +3.12% SSC +3.00% XNET +2.86% GROW +2.46% MGTI +1.43%

    Gapping down
    AAPL -2.5% on reports of on reports out of Taiwan for reduced iPhone X orders
    Suppliers (SMH): LITE -3% SWKS -2.8%, QRVO -2.5%, CRUS -2.4%, FNSR -2%, MU -1.8%, AVGO -1.6%, JBL --1.5%, AMAT -1.3%, XLNX -0.6%, OLED -1%, TXN -0.3%
    Other tech stocks indicated lower (QQQ): NVDA -1%, AMD -1%, MSFT -0.5%
    News:
    PTLA (-5%) FDA will extend its review of the Biologics License Application for AndexXa by 90 days
    Analyst comments:
    AGRX (-8%) downgraded at Janney and William Blair after receiving complete response letter from the FDA for Twirla on Friday morning

    Briefing.com

Teemade nimekirja